Financial Snapshot

Revenue
$81.48M
TTM
Gross Margin
39.89%
TTM
Net Earnings
-$92.10M
TTM
Current Assets
Q2 2024
Current Liabilities
Q2 2024
Current Ratio
31.78%
Q2 2024
Total Assets
Q2 2024
Total Liabilities
Q2 2024
Book Value
-$44.54M
Q2 2024
Cash
Q2 2024
P/E
-0.6956
Sep 06, 2024 EST
Free Cash Flow
-$69.00K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017
Revenue $97.44M $118.6M $104.6M $57.64M $19.03M $3.766M $721.0K
YoY Change -17.83% 13.4% 81.43% 202.83% 405.36% 422.32%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017
Revenue $97.44M $118.6M $104.6M $57.64M $19.03M $3.766M $721.0K
Cost Of Revenue $51.54M $77.43M $55.17M $21.12M $10.85M $2.409M $1.039M
Gross Profit $45.89M $41.15M $49.40M $36.51M $8.181M $1.357M -$318.4K
Gross Profit Margin 47.1% 34.7% 47.24% 63.35% 42.99% 36.03% -44.16%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017
Selling, General & Admin $63.41M $62.80M $58.40M $43.67M $34.02M $13.14M $4.338M
YoY Change 0.97% 7.53% 33.74% 28.35% 158.96% 202.83%
% of Gross Profit 138.17% 152.61% 118.23% 119.6% 415.87% 968.17%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.560M $8.339M $6.636M $8.563M $4.171M $545.0K $70.29K
YoY Change -33.33% 25.66% -22.5% 105.3% 665.32% 675.36%
% of Gross Profit 12.12% 20.26% 13.43% 23.45% 50.98% 40.16%
Operating Expenses $66.74M $65.99M $63.50M $69.12M $188.0M $13.52M $4.338M
YoY Change 1.14% 3.91% -8.13% -63.24% 1290.38% 211.71%
Operating Profit -$20.85M -$24.84M -$14.11M -$32.61M -$179.8M -$12.17M -$4.657M
YoY Change -16.06% 76.07% -56.74% -81.87% 1378.22% 161.25%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017
Interest Expense $13.81M -$9.151M -$12.86M $15.78M $5.559M -$1.544M $470.2K
YoY Change -250.86% -28.82% -181.48% 183.85% -460.04% -428.4%
% of Operating Profit
Other Income/Expense, Net -$16.78M $13.22M $47.00K $763.0K $2.500M -$38.00K -$152.5K
YoY Change -226.95% 28021.28% -93.84% -69.48% -6678.95% -75.09%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017
Pretax Income -$37.63M -$36.97M -$24.36M -$44.94M -$178.0M -$9.948M -$4.339M
YoY Change 1.77% 51.78% -45.8% -74.75% 1689.57% 129.26%
Income Tax $7.092M $9.907M $13.93M $15.05M $966.0K $105.0K $0.00
% Of Pretax Income
Net Earnings -$91.65M -$46.90M -$38.31M -$47.05M -$182.0M -$8.748M -$3.589M
YoY Change 95.42% 22.42% -18.58% -74.15% 1980.59% 143.75%
Net Earnings / Revenue -94.06% -39.55% -36.64% -81.64% -956.34% -232.29% -497.76%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.14 -$0.07 -$64.82K -$90.38K -$433.0K -$25.70K -$24.78M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017
Cash & Short-Term Investments $3.398M $15.19M $22.58M $18.93M $5.789M $1.435M $3.609M
YoY Change -77.63% -32.73% 19.27% 227.03% 303.41% -60.23%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $5.020M $1.207M $2.232M $2.275M $2.198M $272.0K $125.0K
YoY Change 315.91% -45.92% -1.89% 3.5% 708.09% 117.58%
Inventory $17.09M $25.59M $20.09M $18.04M $9.825M $4.840M $19.17K
Prepaid Expenses
Receivables $3.682M $7.391M $1.946M $437.0K $597.0K $0.00 $18.58K
Other Receivables $4.725M $3.887M $4.028M $5.055M $11.83M $3.933M $71.49K
Total Short-Term Assets $33.91M $53.27M $50.87M $44.74M $30.24M $10.48M $3.843M
YoY Change -36.34% 4.7% 13.72% 47.93% 188.56% 172.72%
Property, Plant & Equipment $155.1M $195.4M $143.2M $96.08M $62.58M $19.85M $5.506M
YoY Change -20.63% 36.47% 48.99% 53.54% 215.28% 260.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $759.0K $0.00
YoY Change -100.0%
Other Assets $2.419M $5.615M $5.364M $4.305M $8.699M $789.0K $306.8K
YoY Change -56.92% 4.68% 24.6% -50.51% 1002.53% 157.18%
Total Long-Term Assets $230.0M $291.5M $204.7M $160.0M $172.5M $49.99M $9.936M
YoY Change -21.07% 42.41% 27.9% -7.21% 245.0% 403.12%
Total Assets $264.0M $344.7M $255.5M $204.8M $202.7M $60.47M $13.78M
YoY Change
Accounts Payable $11.42M $12.70M $2.131M $4.722M $5.866M $2.043M $401.4K
YoY Change -10.13% 496.01% -54.87% -19.5% 187.13% 408.99%
Accrued Expenses $10.73M $18.74M $13.04M $8.336M $4.437M $154.8K
YoY Change -42.73% 43.74% 56.43% 87.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.795M
YoY Change -100.0%
Long-Term Debt Due $25.63M $9.059M $6.197M $5.024M $6.190M $9.240M $0.00
YoY Change 182.92% 46.18% 23.35% -18.84% -33.01%
Total Short-Term Liabilities $104.0M $77.45M $48.84M $37.78M $18.85M $12.16M $4.532M
YoY Change 34.28% 58.59% 29.26% 100.42% 55.02% 168.34%
Long-Term Debt $58.54M $75.11M $64.62M $61.99M $81.80M $45.00K $9.436M
YoY Change -22.05% 16.23% 4.23% -24.22% 181675.56% -99.52%
Other Long-Term Liabilities $140.9M $155.5M $96.70M $56.25M $27.29M $0.00 $367.5K
YoY Change -9.4% 60.85% 71.92% 106.11% -100.0%
Total Long-Term Liabilities $199.5M $230.7M $161.3M $118.2M $109.1M $45.00K $9.804M
YoY Change -13.52% 42.98% 36.44% 8.39% 242320.0% -99.54%
Total Liabilities $315.5M $316.5M $218.1M $162.6M $127.9M $10.77M $14.34M
YoY Change -0.32% 45.12% 34.12% 27.11% 1087.78% -24.87%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017
Basic Shares Outstanding 649.7M shares 633.0M shares
Diluted Shares Outstanding 649.7M shares 633.0M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $64.064 Million

About 4Front Ventures Corp

4Front Ventures Corp. operates as a retail and brand development company in the cannabis sector. The company is headquartered in Phoenix, Arizona. The company went IPO on 2006-12-05. The firm manufactures and distributes a portfolio of over 25 cannabis brands including Mission, the Hunt, Marmas, Crystal Clear, Legends, and Island. The firm distributes its products through third party retail outlets, as well as the Company's chain of branded dispensaries. The company operates through two segments: THC Cannabis and CBD Wellness. THC Cannabis segment consists of five dispensaries and four production and cultivation facilities across Illinois and Massachusetts. Also, as part of its THC Cannabis segment, the Company leases real estate, sells equipment and supplies, and licenses intellectual property to cannabis producers in the state of Washington. Its dispensaries are branded under the MISSION retail brand. The Company’s CBD Wellness segment sells non-THC hemp derived products across the United States.

Industry: Medicinal Chemicals & Botanical Products Peers: Biote Corp CymaBay Therapeutics, Inc. Oramed Pharmaceuticals Inc Johnson & Johnson Liquidia Corp OptiNose Inc Provention Bio, Inc.